B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ADRB3

MOLECULAR TARGET

adrenoceptor beta 3

UniProt: P13945NCBI Gene: 15531 compounds

ADRB3 (adrenoceptor beta 3) is targeted by 31 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ADRB3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on3.5333
2Propranolol2.9418
3Norepinephrine Precursor of epinephrine that is secreted by2.208
4Alprenolol1.795
5Epinephrine1.614
6Practolol1.614
7Pindolol1.393
8Sotalol1.393
9Bisoprolol1.102
10Bunolol1.102
11Bupranolol1.102
12Carvedilol1.102
13Ritodrine1.102
14Levalbuterol0.691
15Simvastatin0.691
16Acebutolol0.691
17Levalbuterol0.691
18Aripiprazole0.691
19Atenolol0.691
20Carteolol0.691
21Celecoxib0.691
22Celiprolol0.691
23Clotrimazole0.691
24Dihydroergotamine0.691
25Fenoterol0.691
26Labetalol0.691
27Loratadine0.691
28Nadolol0.691
29Phenylephrine0.691
30Tetrahydropapaveroline0.691
31Timolol0.691

About ADRB3 as a Drug Target

ADRB3 (adrenoceptor beta 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 31 compounds with documented ADRB3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ADRB3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.